Pfizer is likely to receive almost $5 billion from a $10 billion pandemic funding bill being considered by lawmakers, Bloomberg reports.
Officials told the news outlet that the U.S. government owes Pfizer $5 billion for 10 million courses of the company’s antiviral pills it ordered in January when the omicron variant was at its height.
“We continue to collaborate with the U.S. government to help broaden patient access to Paxlovid, and we are confident that the administration will fulfill its purchasing commitments,” a Pfizer spokesperson told Bloomberg in a statement.
Hellbound and Down 